{
  "Variants Include": [
    {
      "Gene": "LAMA2",
      "variants": [
        {
          "HGVS": "NM_001170250.2:c.1234A>G",
          "cDNA Change": {
            "transcript": "NM_001170250.2",
            "ref": "A",
            "alt": "G",
            "position": "1234"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "G",
            "position": "412"
          },
          "Description in input context": "c.1234A>G (p.M412G) - This variant disrupts α-Laminin-2 expression and function."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Limb-Girdle Muscular Dystrophy",
    "MONDO": "MONDO:0003086"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunofluorescence Staining",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Muscle Cells from LGMD Patients",
        "Description": "Primary muscle cells were isolated from muscle biopsies of patients diagnosed with Limb-Girdle Muscular Dystrophy and cultured in vitro."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001170250.2:c.1234A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "Immunofluorescence staining showed significantly reduced α-Laminin-2 expression in muscle cells harboring the c.1234A>G variant compared to control cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed using muscle cells from three independent patients."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was imaged three times to account for potential technical variability."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Muscle cells from healthy donors were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells were treated with a Laminin-2 antibody blocker to confirm specificity."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare the intensity of immunostaining."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Immunostaining intensity greater than 200 arbitrary units.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Immunostaining intensity less than 100 arbitrary units.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}